Liquidia Shares Plunge After Court Ruling Invalidates Yutrepia Patent
Liquidia (LQDA) shares fell sharply after a Delaware court ruled that its inhaled drug Yutrepia infringes on two claims of a United Therapeutics (UTHR) patent. The ruling follows a 57% drop in LQDA shares on Wednesday.